Skip to content
healthcare.dev

Rivaroxaban

NDC 59651-849, Rivaroxaban, tablet, film coated, from Aurobindo Pharma Limited.

Product NDC
59651-849
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208544
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59651-849 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RIVAROXABAN2.5 mg/1

Pharmacologic classes

Factor Xa Inhibitor [EPC]; Factor Xa Inhibitors [MoA]

Package NDCNDC-11Package
59651-849-1859651084918180 TABLET, FILM COATED in 1 BOTTLE (59651-849-18)
59651-849-605965108496060 TABLET, FILM COATED in 1 BOTTLE (59651-849-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/bcb0e6e7-3006-4d82-8009-c5fddbbfc80d
  • NADAC price for package 59651084918

    GET /v1/drugs/nadac/59651084918
  • NADAC price for package 59651084960

    GET /v1/drugs/nadac/59651084960

Use it

Look up 59651-849 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59651-849 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59651-849. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.